Every SEC Form 3/4/5 on record for this filer (CIK 1543792) — 5 issuers, 33 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| NAUT | Nautilus Biotechnology, Inc. | Director | 2021-06-09 → 2026-06-22 | 7 | $225,500 |
| HALO | HALOZYME THERAPEUTICS, INC. | Director | 2016-05-06 → 2026-05-07 | 14 | −$4M |
| TLIS | Talis Biomedical Corp | Director · lapsed | 2021-02-11 → 2023-06-12 | 4 | $1M |
| DMTK | DermTech, Inc. | Director · lapsed | 2019-09-09 → 2023-06-05 | 9 | $999,991 |
| TROV | Trovagene, Inc. | Chief Commercial Officer · lapsed | 2015-08-24 → 2016-01-06 | 2 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| HALO | 2024-08-14 | Sell | 9,881 | $57.70 | $570,134 | 69,874 |
| HALO | 2024-08-13 | Sell | 10,000 | $56.19 | $561,900 | 79,755 |
| HALO | 2024-08-12 | Sell | 10,000 | $55.72 | $557,200 | 89,755 |
| HALO | 2024-06-12 | Sell | 10,000 | $50.62 | $506,200 | 99,755 |
| HALO | 2024-06-11 | Sell | 10,000 | $50.01 | $500,100 | 109,755 |
2 of 5 issuers are covered and open a security page; the rest are on file here only.
